This HTML5 document contains 186 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-dehttp://de.dbpedia.org/resource/
dbpedia-shhttp://sh.dbpedia.org/resource/
dcthttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
dbpedia-kohttp://ko.dbpedia.org/resource/
n17https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/class/yago/
n21https://global.dbpedia.org/id/
umbel-rchttp://umbel.org/umbel/rc/
wdrshttp://www.w3.org/2007/05/powder-s#
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
n8http://dbpedia.org/resource/List_of_drugs:
n34http://commons.wikimedia.org/wiki/Special:FilePath/Nisoxetine.svg?width=
rdfshttp://www.w3.org/2000/01/rdf-schema#
n7http://dbpedia.org/resource/PPPA_(drug)
n29http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n10http://localhost:8890/about/id/entity/http/dbpedia.org/resource/
dbpedia-srhttp://sr.dbpedia.org/resource/
n27http://rdf.freebase.com/ns/m.
n30http://dbpedia.org/resource/Nisoxetine#
n26https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/resource/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n36http://commons.wikimedia.org/wiki/Special:FilePath/Nisoxetine.
n22http://dbpedia.org/resource/David_T.
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
n25http://en.wikipedia.org/wiki/Nisoxetine?oldid=1107676221&ns=
n33https://covidontheweb.inria.fr:4443/about/id/entity/http/dbpedia.org/resource/Template:
xsdhhttp://www.w3.org/2001/XMLSchema#
wdhttp://www.wikidata.org/entity/
n35http://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/
Subject Item
dbr:Nisoxetine
rdf:type
dbo:Drug dbo:ChemicalSubstance yago:Abstraction100002137 yago:Substance100019613 yago:OrganicCompound114727670 wd:Q8386 yago:Matter100020827 yago:Material114580897 yago:Chemical114806838 yago:Compound114818238 yago:Relation100031921 yago:Part113809207 yago:WikicatPhenolEthers umbel-rc:DrugProduct yago:Hydrocarbon114911057 yago:WikicatAmines yago:MethaneSeries114951377 n29:ChemicalObject yago:Quintessence114847103 yago:Element114840755 yago:Amine114739004 yago:AliphaticCompound114601294 yago:PhysicalEntity100001930 owl:Thing yago:WikicatAromaticCompounds yago:AromaticCompound114610088
rdfs:label
니속세틴 Nisoxetine Nisoxetin
rdfs:comment
Nisoxetine, originally synthesized in the Lilly research laboratories during the early 1970s, is a potent and selective inhibitor for the reuptake of norepinephrine (noradrenaline) into synapses. It currently has no clinical applications in humans, although it was originally researched as an antidepressant. Nisoxetine is now widely used in scientific research as a standard selective norepinephrine reuptake inhibitor. It has been used to research obesity and energy balance, and exerts some local analgesia effects. Nisoxetin (LY-94939) ist ein Selektiver Noradrenalin-Wiederaufnahmehemmer (NARI). Ursprünglich wurde es als Antidepressivum entwickelt, kam aber nicht über die Entwicklungsstufe hinaus. Es gilt allerdings in der wissenschaftlichen Forschung als „Standard-NARI“ und wird als solches häufig verwendet. Es wird als Racemat eingesetzt. 니속세틴(Nisoxetine, LY-94939)은 노르에피네프린의 재흡수를 억제하는 약이다. 이성질체와 함께 라세믹 혼합물이다. 최근에는 니속세틴을 사람에게 투여하지 않으나, NRI 원래 우울증 치료제로서 연구와 현재 NRL 선별 기준으로서의 과학 연구에 널리 사용된다.
owl:differentFrom
dbr:Ansoxetine
owl:sameAs
dbr:Nisoxetine wd:Q906885 dbpedia-ko:니속세틴 dbpedia-sh:Nizoksetin dbpedia-sr:Nizoksetin n21:53ukt n27:03y6bwv dbpedia-de:Nisoxetin yago-res:Nisoxetine
foaf:topic
n7: dbr:RTI-51 n8:_Ni dbr:RTI-113 dbr:Synephrine dbr:RTI-31 dbr:RTI-177 dbr:Norepinephrine_reuptake_inhibitor n22:_Wong dbr:PCP_site_2 dbr:Serotonin–norepinephrine–dopamine_reuptake_inhibitor dbr:Monoamine_transporter dbr:Monoamine_reuptake_inhibitor dbr:List_of_adrenergic_drugs dbr:Pharmacology_of_antidepressants n30:this dbr:C17H21NO2 wikipedia-en:Nisoxetine dbr:N-Methyl-PPPA
foaf:depiction
n36:svg
wdrs:describedby
n10:Lean_body_mass n17:Quintessence114847103 n26:Synapse n26:Anticholinergic n26:Racemic n17:WikicatAromaticCompounds n17:Chemical114806838 n26:Inhibitor n17:OrganicCompound114727670 n17:Part113809207 n26:Atomoxetine n17:Compound114818238 n33:Fdacite
dbp:kegg
D05173
dbp:legalStatus
Never marketed
dct:subject
dbc:Catechol_ethers dbc:Amines dbc:Norepinephrine_reuptake_inhibitors dbc:Antidepressants
dbo:wikiPageID
16454909
dbo:wikiPageRevisionID
1107676221
dbo:wikiPageWikiLink
dbr:Diphenhydramine dbr:Desipramine dbr:Serotonin dbr:Fluoxetine dbr:Norepinephrine_transporter dbr:Tyramine dbr:Carbon-11 dbr:Pro-opiomelanocortin dbr:Dissociation_constant dbc:Catechol_ethers dbr:Bupropion dbr:Norepinephrine dbr:Mazindol dbr:Eli_Lilly_and_Company dbr:Norepinephrine_reuptake_inhibitor dbr:Electrocardiogram dbr:Lean_body_mass dbr:Atomoxetine dbr:In_vitro dbr:Selective_serotonin_reuptake_inhibitor dbr:Hypothalamic dbr:Neuropeptide_Y dbc:Amines dbr:Apomorphine dbr:Arcuate_nucleus dbr:Synapse dbr:Dopamine dbr:Racemic dbr:Obesity dbr:Hypothalamus dbr:Neurotransmission dbr:Isomer dbr:Monoamine_neurotransmitter dbr:Tricyclic_antidepressants dbr:Isotopic_labeling dbr:Locus_coeruleus dbr:Anticholinergic dbc:Norepinephrine_reuptake_inhibitors dbr:Synaptosomes dbr:Tetrodotoxin dbr:Blood_test dbr:Positron_emission_tomography dbr:Racemic_mixture dbr:Tritium dbr:Local_anesthetic dbr:Superior_cervical_ganglia dbc:Antidepressants dbr:GBR-12783 dbr:Reboxetine dbr:Catecholamine dbr:Serotonin–norepinephrine_reuptake_inhibitor dbr:Molar_concentration dbr:Lidocaine
foaf:isPrimaryTopicOf
wikipedia-en:Nisoxetine
dbp:chirality
dbr:Racemic_mixture
prov:wasDerivedFrom
n25:0
n35:hypernym
dbr:Inhibitor
dbo:abstract
Nisoxetine, originally synthesized in the Lilly research laboratories during the early 1970s, is a potent and selective inhibitor for the reuptake of norepinephrine (noradrenaline) into synapses. It currently has no clinical applications in humans, although it was originally researched as an antidepressant. Nisoxetine is now widely used in scientific research as a standard selective norepinephrine reuptake inhibitor. It has been used to research obesity and energy balance, and exerts some local analgesia effects. Researchers have attempted to use a carbon-labeled form of nisoxetine for positron emission tomography (PET) imaging of the norepinephrine transporter (NET), with little success. However, it seems that tritium labeled nisoxetine (3H-nisoxetine, 3H-NIS) is a useful radioligand for labeling norepinephrine uptake sites in vitro, which nisoxetine and other antagonists for NET are able to inhibit. 니속세틴(Nisoxetine, LY-94939)은 노르에피네프린의 재흡수를 억제하는 약이다. 이성질체와 함께 라세믹 혼합물이다. 최근에는 니속세틴을 사람에게 투여하지 않으나, NRI 원래 우울증 치료제로서 연구와 현재 NRL 선별 기준으로서의 과학 연구에 널리 사용된다. Nisoxetin (LY-94939) ist ein Selektiver Noradrenalin-Wiederaufnahmehemmer (NARI). Ursprünglich wurde es als Antidepressivum entwickelt, kam aber nicht über die Entwicklungsstufe hinaus. Es gilt allerdings in der wissenschaftlichen Forschung als „Standard-NARI“ und wird als solches häufig verwendet. Es wird als Racemat eingesetzt.
dbo:thumbnail
n34:300
dbp:c
17
dbp:h
21
dbp:n
1
dbp:width
175
dbp:iupharLigand
4637
dbp:atcPrefix
None
dbp:casNumber
53179
dbp:chebi
73410
dbp:chembl
295467
dbp:chemspiderid
4344
dbp:iupacName
-3
dbp:o
2
dbp:pubchem
4500
dbp:smiles
CNCCCOC2=CC=CC=C2OC
dbp:stdinchi
1
dbp:stdinchikey
ITJNARMNRKSWTA-UHFFFAOYSA-N
dbp:synonyms
-γ--N-methyl-benzenepropanamine hydrochloride LY-94939,
dbp:unii
17
dbp:verifiedfields
changed
dbp:verifiedrevid
492910405
dbp:watchedfields
changed
dbo:casNumber
53179-07-0
dbo:chEBI
73410
dbo:chEMBL
295467
dbo:fdaUniiCode
17NV064B2D
dbo:kegg
D05173
dbo:pubchem
4500
dbo:wikiPageLength
24615
dbp:wikiPageUsesTemplate
dbt:Drugbankcite dbt:Drugbox dbt:Keggcite dbt:Antidepressants dbt:Reflist dbt:Short_description dbt:Chemspidercite dbt:Stdinchicite dbt:Distinguish dbt:Cascite dbt:Ebicite dbt:Monoamine_reuptake_inhibitors dbt:Fdacite